Upcoming Events

Follow Us On Twitter

The Kentucky Society of Clinical Oncology focuses on providing our members with the most up to date information regarding patient care and practice management.

Investigators are unclear about the factors driving the explosive growth in incidence of appendiceal cancer over the past 2 decades. @drholowatyj @KU_Leuven @VUMC_Cancer #oncology http://ow.ly/o9kf50Notu8

When the fully human IgG4 monoclonal antibody SRK-181 was given as a monotherapy or w/ anti–PD-1 or PD-L1 agents in pts w/ locally advanced or metastatic solid tumors, it was found to be generally well tolerated. @MDAndersonNews #oncology http://ow.ly/CoBH50NotqA

Pradnya D. Patil, MD, FACP, of @ClevelandClinic, discusses unmet needs that remain to be addressed with the use of immunotherapy in patients with non–small cell lung cancer. #lcsm http://ow.ly/hZpL50NrMkI

Research showing benefits w/ olaparib & niraparib in pts w/ ovarian cancer, regardless of BRCA mutation or hHRD status, is setting the stage for continued advances w/ these agents that may fulfill unmet needs in this population @AtriumHealth #ovca http://ow.ly/ft1w50Not5q

Load More